P Madde
Overview
Explore the profile of P Madde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reddi H, Driscoll C, Madde P, Milosevic D, Hurley R, McDonough S, et al.
Cancer Gene Ther
. 2013 Apr;
20(5):267-75.
PMID: 23598436
Anaplastic thyroid cancer (ATC) is an aggressive, fatal disease unresponsive to traditional therapies, generating a need to develop effective therapies. The PAX8/PPARγ fusion protein (PPFP) has been shown to favorably...
2.
Reddi H, Madde P, McDonough S, Trujillo M, Morris 3rd J, Myers R, et al.
Cancer Gene Ther
. 2012 Jul;
19(9):659-65.
PMID: 22790962
Anaplastic thyroid cancer is an extremely aggressive disease resistant to radioiodine treatment because of loss of sodium iodide symporter (NIS) expression. To enhance prognosis of this fatal cancer, we validated...
3.
Reddi H, Madde P, Cohen Y, Bangio L, Breitbart E, Harats D, et al.
Genes Cancer
. 2012 Jun;
2(10):993-5.
PMID: 22701765
VB-111 is an engineered antiangiogenic adenovirus that expresses Fas-c in angiogenic blood vessels and has previously been shown to have significant antitumor activity in vitro and in vivo in Lewis...
4.
Reddi H, Madde P, Marlow L, Copland J, McIver B, Grebe S, et al.
Genes Cancer
. 2010 Sep;
1(5):480-492.
PMID: 20827445
The PAX8/PPARγ fusion protein (PPFP) occurs in 36% of human follicular thyroid carcinoma (FTC) and is associated with favorable prognosis. To elucidate the function of PPFP in FTC, we analyzed...
5.
Reddi H, Madde P, Reichert-Eberhardt A, Galanis E, Copland J, McIver B, et al.
Cancer Gene Ther
. 2008 Jun;
15(11):750-7.
PMID: 18583996
Anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid cancer variant, accounting for 1-2% of all cases, but 33% of deaths, and exhibiting an average life expectancy of 5 months....